DYNT: Dynatronics Corporation Forward P/E Multiple

Graphic logo of dynatronics.com (DYNT)

Dynatronics Corporation (DYNT) has created a closed ecosystem of rehabilitation systems, deeply integrating its solutions into the practice of sports physicians. The company's current forward P/E confirms the market valuation of this strategy, where the parameter is 0.00. Rising demand driven by an aging population and the outsourcing of standardized production to external partners while retaining core technologies ensure sustainable business development.

Dynatronics Corporation - DYNT Price to Expected Earnings Ratio (period 07/04/2022 - 08/04/2024)
Brand item of dynatronics.com

Export control risks and trade barriers in the medtech sector directly impact the future profitability of Dynatronics Corporation (DYNT). The company's forward P/E ratio reflects the market value of one unit of expected net income one year from now, allowing for an assessment of the asset's overbought status relative to growth forecasts. The price action of the company's forward P/E ratio helps investors filter out market noise and determine a fair valuation level for the business.

Competitors of Dynatronics Corporation

Future Price to Earnings Boston Scientific Corporation (BSX)|Future Price to Earnings EW (Edwards)|Forward P/E Multiple RMD (ResMed Corp)|Market Cap to Projected Earnings Insulet Inc. (PODD)|ZBH: Projected Price to Earnings|Price to Expected Earnings Ratio COO|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Inc (GMED)|TMDX (TransMedics Group) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec Corp)|Projected Price to Earnings AORT (Artivion, Inc.)|ENOV (enovis.com) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Holdings Corporation IART|ESTA - Projected Price to Earnings|Beta Bionics Corp - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED Inc.|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen) - Forward P/E Multiple|SI-BONE Inc (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Projected Price to Earnings Bioventus Global BVS|Forward P/E Multiple KIDS (OrthoPediatrics)|Forward P/E Multiple treace.com TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight Corp) - Projected Price to Earnings|ClearPoint Neuro - Future Price to Earnings Multiple|STXS (Stereotaxis, Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio neurostar.com STIM|Future Price to Earnings Sight Sciences (SGHT)|Orchestra BioMed Inc. (OBIO) - Forward Price to Earnings Multiple|Anika Therapeutics, Inc. - Projected Price to Earnings|Forward P/E Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - Forward P/E Multiple|Market Cap to Projected Earnings Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Future Price to Earnings|Price to Expected Earnings Ratio NMTC (NeuroOne)|Future Price to Earnings Modular Medical Inc|Projected Price to Earnings Myomo Inc (MYO)|Forward P/E Multiple COCH|VVOS - Projected Price to Earnings Ratio|Future Price to Earnings enVVeno Medical Corp. NVNO|SINT: Price to Future Earnings Ratio|TNON: Projected Price to Earnings|Lifeward Ltd. - Market Cap to Future Earnings Ratio|AMIX: Forward P/E Multiple|Price to Future Earnings Ratio IVF|Projected Price to Earnings BBLG|Projected Price to Earnings Ratio Axonics Inc. AXNX|Future Price to Earnings Biolase, Inc. (BIOL)|paragon28.com - Price to Future Earnings Ratio|Forward P/E Multiple INVO (INVO Bioscience)